Get the Stockscreener App
4.87
5.44%
-0.28
Mei Pharma Inc stock is traded at $4.87, with a volume of 347.92K.
It is down -5.44% in the last 24 hours and up +106.36% over the past month.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
See More
Previous Close:
$5.15
Open:
$4.95
24h Volume:
347.92K
Relative Volume:
0.39
Market Cap:
$32.45M
Revenue:
$105.38M
Net Income/Loss:
$17.78M
P/E Ratio:
1.824
EPS:
2.67
Net Cash Flow:
$-50.48M
1W Performance:
-27.74%
1M Performance:
+106.36%
6M Performance:
+70.88%
1Y Performance:
+40.35%
1-Day Range:
$4.67
$4.9988
1-Week Range:
$4.67
$6.88
52-Week Range:
$1.46
$9.00
Mei Pharma Inc Stock (MEIP) Company Profile
Name
Mei Pharma Inc
Sector
Industry
Phone
858-369-7100
Address
11455 EL CAMINO REAL, SAN DIEGO, CA
Compare MEIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEIP
Mei Pharma Inc
|
4.87 | 153.88M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Mei Pharma Inc Stock (MEIP) Latest News
Can MEI Pharma Inc. stock recover from recent declineIn-Depth Stock Trading Volume Analysis - Newser
What catalysts could drive MEI Pharma Inc. stock higher in 2025Best Dividend Data Feed Backed By Experts - jammulinksnews.com
Has MEI Pharma Inc. found a price floorBear Market Safe Zone Technical Analysis - Newser
How to escape a deep drawdown in MEI Pharma Inc.Institutional Holding Behavior Pattern Analysis - Newser
Technical analysis overview for MEI Pharma Inc. stockFree Triple Return Setup with Risk Control - Newser
How to monitor MEI Pharma Inc. with trend dashboardsMachine Learning Intraday Signal Forecast - Newser
When is MEI Pharma Inc. stock expected to show significant growthLow Risk Growth Plan With Low Risk - jammulinksnews.com
Is it the right time to buy MEI Pharma Inc. stockTop Growth Ideas For 2025 - jammulinksnews.com
How MEI Pharma Inc. stock reacts to Fed policy changesSmart Swing Picks with Confirmed Signals - Newser
Will MEI Pharma Inc. stock benefit from AI tech trendsFree Stock Screener With Smart Filters - Newser
Can machine learning forecast MEI Pharma Inc. recoverySmart Entry Watchlist with Daily Analysis - Newser
Volume spikes in MEI Pharma Inc. stock – what they meanControlled Entry Strategy With Safety Analytics - Newser
Sector Leaders Rotate Capital Into MEI Pharma Inc.Entry Plan for Oversold Reversal Stocks Released - metal.it
What markets is MEI Pharma Inc. expanding into Is LIPO stock a good long term investment option - jammulinksnews.com
How does MEI Pharma Inc. compare to its industry peersSwing Trade Target Finder With Low Risk - jammulinksnews.com
What is MEI Pharma Inc. company’s growth strategyBuild wealth faster with high-performing stocks - jammulinksnews.com
What institutional investors are buying MEI Pharma Inc. stockConsistent double returns - jammulinksnews.com
Published on: 2025-07-28 00:30:46 - jammulinksnews.com
How many analysts rate MEI Pharma Inc. as a “Buy”Maximize your investment portfolio’s performance - jammulinksnews.com
Why MEI Pharma Inc. stock attracts strong analyst attentionFree Wealth-Building Investment Strategies - metal.it
What analysts say about MEI Pharma Inc. stockDynamic profit opportunities - PrintWeekIndia
How high can MEI Pharma Inc. stock price go in 2025Free Stock Market Return Analysis - jammulinksnews.com
What drives MEI Pharma Inc. stock priceSuperior risk-adjusted returns - PrintWeekIndia
How MEI Pharma Inc. stock performs during market volatilityAI Powered Stock Call - Newser
Is MEI Pharma Inc. a good long term investmentStrong return on assets - PrintWeekIndia
Aardvark Therapeutics shares rise 1.97% premarket after Mei Pharma files for a $100 million common stock offering. - AInvest
Bitcoin News Today: MEI Pharma Raises $100M for Litecoin Treasury Strategy as Corporate Crypto Holdings Surge to $108B - AInvest
Now Litecoin? Pharmaceuticals Firm Closes Deal to Fund $100M LTC Treasury - Decrypt
MEI Pharma bets 100 million yuan on Litecoin, is the altcoin micro-strategy craze coming?-web3资讯 - Odaily
Mei Pharma Plunges 9.04% Amid Litecoin Reserve Shift - AInvest
MEI Pharma's $100M Litecoin Investment Sparks 111% Stock Surge, Second $100M Raise in Works - AInvest
MEI Pharma Allocates $100M to Litecoin as Strategic Reserve Share Price Surges 172.6% After Announcement - AInvest
MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange - MSN
MEI Pharma Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
MEI Pharma's $100M Shift to Litecoin Treasury: A Bold Move or a Strategic Bet on Digital Assets? - AInvest
MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset - CTOL Digital Solutions
MEI Pharma’s Strategic Shift with Litecoin Treasury - TipRanks
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy - Investing.com
MEI Pharma adopts Litecoin as treasury reserve in $100 million deal - Investing.com Australia
MEI Pharma Allocates $100M to Litecoin, Becoming First US-Listed Company with Cryptocurrency as Primary Reserve; Coin Surges to Multi-Year High - AInvest
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy By Investing.com - Investing.com South Africa
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - MSN
MEI Pharma Trades Cash For LTC - Asianet Newsable
Mei Pharma Inc Stock (MEIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):